Quick Answer
AtriCure, Inc. reported Cash And Cash Equivalents At Carrying Value of $167.43 million for the year ending 2025.
- AtriCure, Inc. showed an increase of +36.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from AtriCure, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), AtriCure, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,780.1%.
- Historical annual values: Fiscal year 2025: $167.43 million | Fiscal year 2024: $122.72 million | Fiscal year 2023: $84.31 million | Fiscal year 2022: $58.10 million | Fiscal year 2021: $43.65 million | Fiscal year 2020: $41.94 million | Fiscal year 2019: $28.48 million | Fiscal year 2018: $32.23 million | Fiscal year 2017: $21.81 million | Fiscal year 2016: $24.21 million | Fiscal year 2015: $23.76 million | Fiscal year 2014: $28.38 million | Fiscal year 2013: $14.89 million | Fiscal year 2012: $7.75 million | Fiscal year 2011: $9.76 million | Fiscal year 2010: $4.23 million | Fiscal year 2009: $8.91 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: